Non-small cell lung cancer
Showing 9 of 0 results
- PFS as a surrogate endpoint for OS in real-world patients with ROS1+ advNSCLC in the United States
World Conference of Lung Cancer
- Real-world characteristics and distant metastasis free survival of patients with early NSCLC treated with chemoimmunotherapy
World Conference of Lung Cancer
- Treatment inequities in patients with metastatic non-small cell lung cancer harboring actionable driver oncogenes in the first-line setting
J Clin Oncol 42, 2024 (suppl 16; abstr e13673)
- Evaluation of real-world response rate in clinical trial-aligned cohorts of patients with lung, colon and breast cancer using machine learning
Poster presented at: ISPOR US 2024; May 5-8, 2024; Atlanta, GA